Skip to main content
Adrian Sacher, MD, Oncology, New York, NY

AdrianGeroldSacherMDMMSc

Oncology New York, NY

Hematologic Oncology, Thoracic Cancer

Assistant Professor of Medicine, Thoracic Oncology & Phase I Drug Development, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, NewYork-Presbyterian

Dr. Sacher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sacher's full profile

Already have an account?

  • Office

    177 Fort Washington Ave
    MHB 6GN 435
    New York, NY 10032
    Phone+1 212-305-3997
    Fax+1 646-317-6321

Education & Training

  • Dana-Farber Cancer Institute
    Dana-Farber Cancer InstituteFellowship, 2014 - 2016
  • Harvard Medical School
    Harvard Medical SchoolMMSc, Genomics and Translational Research, 2014 - 2016
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 2009

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2014 - 2023
  • NY State Medical License
    NY State Medical License 2015 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors  
    David S Hong, Marwan G Fakih, Gregory A Durm, Geoffrey I Shapiro, Gerald S Falchook, Adrian Sacher, Crystal S Denlinger, John C Krauss, Andrew L Coveler, Suresh S Rama..., The New England Journal of Medicine

Press Mentions

  • In Case You Missed It: Roundup from ESMO Congress 2024
    In Case You Missed It: Roundup from ESMO Congress 2024November 19th, 2024
  • Young Investigators Awarded $200k to Study Innovative New Ways to Engage the Body’s Immune System to Fight Lung Cancer
    Young Investigators Awarded $200k to Study Innovative New Ways to Engage the Body’s Immune System to Fight Lung CancerJanuary 15th, 2021
  • Leukemia Drugs Hold Promise for Treatment-Resistant Lung Cancer
    Leukemia Drugs Hold Promise for Treatment-Resistant Lung CancerMarch 20th, 2020
  • Join now to see all